Medacta Group S.A.
MEDGFOTCHealthcare
$83.91
+$0.00(+0.00%)
Market Cap$1.7B
P/E Ratio—
52W High$83.91
52W Low$83.91
Medacta Group S.A. (MEDGF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MEDGF · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 13, 2026EPS Actual
$2.11
Revenue
$0.40B
Est. $0.40B · -0.4%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 13, 2026
After Market Close
MEDGF reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$3.83
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$3.83
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q1 FY2026 | Mar 23, 2026 | — | — | — | — | — | — |
| — Q1 FY2026 | Mar 13, 2026 | — | $2.11 | — | $0.40B | $0.40B | -0.4% |
| — Q3 FY2025 | Sep 8, 2025 | — | $3.54 | — | $0.41B | $0.40B | +1.1% |
| ◌ Q1 FY2025 | Mar 25, 2025 | — | — | — | $0.31B | $0.31B | -0.0% |
| — Q4 FY2024 | Dec 31, 2024 | — | $1.81 | — | $0.31B | — | — |
| ◌ Q3 FY2024 | Sep 25, 2024 | — | — | — | $0.31B | $0.31B | -0.1% |
| — Q2 FY2024 | Jun 20, 2024 | — | $2.05 | — | $0.31B | — | — |
| ◌ Q2 FY2024 | May 17, 2024 | — | — | — | $0.28B | $0.28B | +0.6% |
Q1 FY2026
Mar 23, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 13, 2026
EPS Actual
$2.11
EPS Est.
—
EPS Surpr.
—
Revenue
$0.40B
Q3 FY2025
Sep 8, 2025
EPS Actual
$3.54
EPS Est.
—
EPS Surpr.
—
Revenue
$0.41B
Q1 FY2025
Mar 25, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
$0.31B
Q4 FY2024
Dec 31, 2024
EPS Actual
$1.81
EPS Est.
—
EPS Surpr.
—
Revenue
$0.31B
Q3 FY2024
Sep 25, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
$0.31B
Q2 FY2024
Jun 20, 2024
EPS Actual
$2.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.31B
Q2 FY2024
May 17, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
$0.28B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.3B | $0.3B | $0.3B | 1 |
| Q3 FY2025 | $0.4B | $0.4B | $0.4B | 1 |
| Q2 FY2025 | $0.3B | $0.3B | $0.3B | 1 |
| Q2 FY2024 | $0.3B | $0.3B | $0.3B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Mar 13, 2026 | — | $83.91 | $83.91 | +0.00% |
| — Q3 FY2025 | Sep 8, 2025 | — | $83.91 | $83.91 | +0.00% |
| — Q4 FY2024 | Dec 31, 2024 | — | $83.91 | $83.91 | +0.00% |
| — Q2 FY2024 | Jun 20, 2024 | — | $83.91 | $83.91 | +0.00% |
| — Q1 FY2024 | Feb 28, 2024 | — | $83.91 | $83.91 | +0.00% |
| — Q2 FY2023 | Jun 30, 2023 | — | $83.91 | $83.91 | +0.00% |
Q1 FY2026+0.00%
Report Date
Mar 13, 2026
EPS Beat/Miss
—
Price Before
$83.91
Price After
$83.91
Q3 FY2025+0.00%
Report Date
Sep 8, 2025
EPS Beat/Miss
—
Price Before
$83.91
Price After
$83.91
Q4 FY2024+0.00%
Report Date
Dec 31, 2024
EPS Beat/Miss
—
Price Before
$83.91
Price After
$83.91
Q2 FY2024+0.00%
Report Date
Jun 20, 2024
EPS Beat/Miss
—
Price Before
$83.91
Price After
$83.91
Q1 FY2024+0.00%
Report Date
Feb 28, 2024
EPS Beat/Miss
—
Price Before
$83.91
Price After
$83.91
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$83.91
Price After
$83.91
Beat Rate0 / 6 quarters
Largest Move+0.00% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MEDGF ends December
Medacta Group S.A. (MEDGF) most recently reported earnings on March 13, 2026 for Q1 FY2026, posting EPS of $2.11 (in line with the analyst consensus of —). The next MEDGF earnings date is expected around September 1, 2026.
Each quarter, investors track MEDGF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MEDGF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MEDGF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MEDGF earnings · 4 questionsMedacta Group S.A.'s next earnings report is expected around September 1, 2026. MEDGF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MEDGF historically reports after market close (AMC).
MEDGF earnings datewhen is MEDGF earningsMEDGF next earnings datewhen does MEDGF report earningsMEDGF earnings calendar
▸ Source: FMP · Medacta Group S.A. SEC filings · US GAAP · Medacta Group S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026